Table 1 Clinical characteristics of patients in the NGS and in the PCR cohort. In the NGS cohort 10 patients had Gleason score 7a (3 + 4) and 10 patients had Gleason score 7b (4 + 3), and 13 and 7 patients were classified as intermediate and aggressive risk, respectively, using the D’Amico Risk Classification